We are live on ! Find out more
KM

Kalos Management Portfolio holdings

AUM $46.6M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+11.52%
3 Year Est. Return
+48.48%
5 Year Est. Return
+71.6%
10 Year Est. Return
AUM
$221M
AUM Growth
+$51.4M
Cap. Flow
+$49.8M
Cap. Flow %
22.57%
Top 10 Hldgs %
22.94%
Holding
218
New
92
Increased
40
Reduced
33
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 11.33%
2 Healthcare 8.52%
3 Financials 7.65%
4 Consumer Discretionary 5.62%
5 Industrials 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRLN icon
151
State Street Blackstone Senior Loan ETF
SRLN
$5.31B
$287K 0.13%
+6,110
New +$289K
NYRT
152
DELISTED
New York REIT, Inc.
NYRT
$287K 0.13%
15,718
-296
-2% -$5.86K
MUB icon
153
iShares National Muni Bond ETF
MUB
$45.1B
$280K 0.13%
+3,297
New +$358K
PG icon
154
Procter & Gamble
PG
$343B
$280K 0.13%
+3,495
New +$263K
QCOM icon
155
Qualcomm
QCOM
$176B
$267K 0.12%
+4,127
New +$230K
BA icon
156
Boeing
BA
$165B
$264K 0.12%
+807
New +$278K
HON icon
157
Honeywell
HON
$77.1B
$263K 0.12%
+2,016
New +$268K
RJF icon
158
Raymond James Financial
RJF
$32.5B
$263K 0.12%
+4,425
New +$275K
MDYG icon
159
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.82B
$259K 0.12%
+4,669
New +$251K
IJT icon
160
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.22B
$257K 0.12%
+2,958
New +$272K
IYJ icon
161
iShares US Industrials ETF
IYJ
$1.98B
$254K 0.12%
+3,492
New +$255K
MRTX
162
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$252K 0.11%
+8,250
New +$312K
BRK.B icon
163
Berkshire Hathaway Class B
BRK.B
$1.07T
$246K 0.11%
+1,237
New +$241K
FNDE icon
164
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.46B
$245K 0.11%
8,835
-23,543
-73% -$701K
GYRE icon
165
Gyre Therapeutics
GYRE
$662M
$244K 0.11%
+1,133
New +$199K
RSP icon
166
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$241K 0.11%
+1,237
New +$125K
CVX icon
167
Chevron
CVX
$388B
$240K 0.11%
+2,110
New +$262K
KNOW
168
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
$240K 0.11%
+5,629
New +$232K
WFC icon
169
Wells Fargo
WFC
$261B
$227K 0.1%
+4,154
New +$223K
MMM icon
170
3M
MMM
$89B
$226K 0.1%
+1,222
New +$209K
NGNE icon
171
Neurogene
NGNE
$696M
$226K 0.1%
793
CMCSA icon
172
Comcast
CMCSA
$79.1B
$223K 0.1%
+6,462
New +$211K
VTI icon
173
Vanguard Total Stock Market ETF
VTI
$654B
$217K 0.1%
+1,580
New +$220K
PBJ icon
174
Invesco Food & Beverage ETF
PBJ
$109M
$213K 0.1%
+6,592
New +$216K
XLG icon
175
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
$206K 0.09%
+10,140
New +$194K

Similar funds

Kalos Management's Q2 2018 Portfolio in Review

As of Q2 2018, Kalos Management held 218 positions worth $221M, up 30% from $169M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Kalos Management deployed $49.8M of net new capital in Q2 2018, opening 92 new positions and adding to 40 existing holdings. Its largest new stake was State Street SPDR S&P 600 Small Cap Value ETF: 74,261 shares worth $5.06M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Southwest Airlines, an estimated $2.23M trimmed.

  • Kalos Management's largest Q2 2018 buy was State Street SPDR S&P 600 Small Cap Value ETF: 74,261 shares worth $5.06M.
  • Kalos Management added most to Schwab US Large- Cap ETF in Q2 2018, an estimated $2.82M increase.
  • Kalos Management's biggest Q2 2018 reduction was Southwest Airlines, cutting an estimated $2.23M.
  • Kalos Management fully exited Novo Nordisk in Q2 2018, selling an estimated $3.42M.
  • Kalos Management's ten largest holdings make up 23% of its $221M portfolio in Q2 2018.
  • Kalos Management opened 92 new positions and closed 17 in Q2 2018.
  • Kalos Management's portfolio value rose 30% quarter-over-quarter to $221M.

Based on Kalos Management's 13F filing for Q2 2018, filed 14 Aug 2018.